Evidence map›Paper›PMID 33094120›Full record

ArticleOpen forum infectious diseases2020

Endothelial Dysfunction Is Related to Monocyte Activation in Antiretroviral-Treated People With HIV and HIV-Negative Adults in Kenya.

Tecla M Temu, Stephen J Polyak, Jerry S Zifodya, Celestine N Wanjalla, John R Koethe, Sarah Masyuko, Jerusha Nyabiage, John Kinuthia, Ana L Gervassi, Julius Oyugi and 2 more

Open access · goldAbstract read
In one paragraph

Article in Open forum infectious diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 20 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. CD3bioRxiv : the preprint server for biology · 2024
    Article
  7. Review
  8. Article
  9. Article
  10. Observational
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 2 countries.

Tecla M TemuDepartment of Global Health, University of Washington, Seattle, Washington, USA.ORCID 0000-0002-0056-4143
Stephen J PolyakDepartment of Laboratory Medicine, University of Washington, Seattle, Washington, USA.
Jerry S ZifodyaDepartment of Medicine, Tulane University, New Orleans, Louisiana, USA.
Celestine N WanjallaDepartment of Medicine, Vanderbilt University, Nashville, Tennessee, USA.
John R KoetheDepartment of Medicine, Vanderbilt University, Nashville, Tennessee, USA.
Sarah MasyukoDepartment of Global Health, University of Washington, Seattle, Washington, USA.
Jerusha NyabiageDepartment of Global Health, University of Washington, Seattle, Washington, USA.
John KinuthiaDepartment of Global Health, University of Washington, Seattle, Washington, USA.
Ana L GervassiCenter for Infectious Disease Research, Seattle Biomedical Research Institute, Seattle, Washington, USA.
Julius OyugiDepartment of Medical Microbiology, University of Nairobi, Nairobi, Kenya.
Stephanie PageDivision of Metabolism, Endocrinology and Nutrition, University of Washington, Seattle, Washington, USA.
Carey FarquharDepartment of Global Health, University of Washington, Seattle, Washington, USA.
University of Washington · USVanderbilt University · USCenter for Infectious Disease Research · USTulane University · USUniversity of Nairobi · KE

Funding

University of Washington/Fred Hutch Center for AIDS ResearchP30AI027757 · NIAID · UNIVERSITY OF WASHINGTON · PI Judith Tsui · 1988 to 2026
$104.9M
The Gut Microbiota, Inflammation and Cardiovascular Disease in HIV-InfectedIndividuals.K01HL147723 · NHLBI · UNIVERSITY OF WASHINGTON · PI TEMU, TECLA MTUI · 2020 to 2022
$505k
Predicting Early Cardiovascular Risk among HIV-Infected and Uninfected Kenyan AdultsR21TW010459 · FIC · UNIVERSITY OF WASHINGTON · PI FARQUHAR, CAREY, PAGE, STEPHANIE T · 2016 to 2017
$463k
FIC NIH HHS R21 TW010459NHLBI NIH HHS K01 HL147723NHLBI NIH HHS L30 HL165482NIAID NIH HHS P30 AI027757
6 · The paper itself

Abstract

backgroundResidual monocyte activation may contribute to increased risk for endothelial dysfunction and subsequent atherosclerotic cardiovascular diseases (CVDs) among people with HIV (PWH) on antiretroviral therapy (ART). We examined the relationship between monocyte activation and endothelial activation in PWH in Kenya.

methodsSerum levels of markers of endothelial activation (soluble/circulating intercellular [sICAM-1] and vascular [sVCAM-1] cell adhesion molecule-1), intestinal barrier dysfunction (intestinal fatty acid binding protein [I-FABP]), and monocyte activation (soluble CD14 [sCD14]) were measured in 275 PWH on ART and 266 HIV-negative persons. Linear regression was used to evaluate associations, adjusting for demographic and traditional CVD risk factors.

resultsAmong 541 participants, the median age was 43 years, 50% were female, and most PWH were virally suppressed (97%). sICAM-1 and sVCAM-1 levels were significantly higher in PWH than in HIV-negative participants (

conclusionsDespite viral suppression, African PWH have evidence of enhanced endothelial activation associated with sCD14, suggesting that monocyte activation plays a role in atherosclerotic plaque development. Future studies are needed to determine mechanistic pathways leading to monocyte activation in this population.

Indexed as

Africaantiretroviral therapyendothelial activationHIVI-FABPinflammationsCD14

Identifiers

PMID33094120
PMCPMC7568437
OpenAlexW3085829935

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.